The current study aims to evaluate the value of susceptibility weighted imaging (SWI) and contrast-enhanced T1-weighted imaging (CE-T1WI) radiomics features in predicting isocitrate dehydrogenase1 (IDH1) genotype of diffuse gliomas and build prediction models. It was concluded that SWI and CE-T1WI radiomics features can effectively predict the IDH1 genotype of diffuse gliomas, and CE-T1WI performed better. By combining SWI with CE-T1WI radiomics features, the prediction performance can be improved.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords